Notis Global Inc (OTCMKTS:NGBL) Gets A Fresh Start

Notis Global Inc (OTCMKTS:NGBL) has a new name and a new symbol as it looks to erase the stench that was Medbox Inc. Medbox left investors with large losses as the company went on a wave of dilution and socked it to the average investor. As Notis Global, the company is hoping that it can bring in new investors and get investors to forget about its past.While Notis Global is still the same old Medbox, the company is looking to benefit from the renewed interest in pot stocks. We've been talking about this ever since 2016 rolled around. Roughly 14 states could legalize marijuana this year, adult-use cannabis or possibly both, either at the ballot box or through state legislatures. While it’s doubtful all those states will be successful, there’s a good chance at least a handful will legalize in 2016. No other single year has offered such incredible promise in terms of the sheer volume of states that could legalize, thanks to other pioneering marijuana markets and growing support for cannabis in general.The ArcView Group just reported that legal sales of cannabis grew to $5.4 billion in 2015, up from $4.6 billion in 2014. Demand is expected to remain strong this year and the research firm forecasts sales of $6.7 billion. Nonmedicinal adult use accounted for $998 million of the total sales in 2015, up from $351 million in 2014, according to the ArcView/New Frontier report summary.The most surprising aspect for us at Insider Financial is the fact that marijuana stocks have underperformed the major market indices. This sector is probably the fastest-growing industry in America right now and most of the public companies in the space are trading for pennies. With the potential interest coming from all walks of life, we think you’ll see bottom fishers looking for a place to invest.Pot stocks got active this month after GW Pharmaceuticals plc (NASDAQ:GWPH) reported a successful phase three clinical trial that proved its drug Epidiolex significantly reduced seizures in children with Dravet Syndrome. This news created momentum across the entire marijuana spectrum. Investors see the potential for cannabis-based drugs to replace addictive pills like Oxycodone. Many are now seeing the bigger picture with cannabis and that it's not just for recreational use, but can also treat diseases. This will lead to more widespread acceptance and get not only Wall Street behind pot stocks, but the regulatory environment in Washington DC as well. These two factors will send pot stocks exploding up the charts.In looking at Notis Global, the company has positioned itself to benefit from coming marijuana boom. Notis Global says that it is “a pioneer in the burgeoning, multi-billion dollar legal cannabis industry. The company and its partners are working to bring best practices and drive significant revenues in the cannabis industry. Through key partnerships, Notis is a leading U.S. based provider of Cannabidiol (CBD) oil and is a partner in one of the largest hemp operations in the United States. Notis also invests and partners in the the operation of several licensed retail dispensaries across the country.” In the latest shareholder update, the company said:

In conjunction with its partners, including Whole Hemp Company, Notis is on track to be one of the largest U.S. growers, processors and revenue producers of hemp products from seed to sale. With cultivation facilities located in Pueblo, Colo., Notis uses best farming practices, growing product outdoors and in greenhouse facilities. Notis is positioned to become a leading U.S. based provider of Cannabidiol (CBD) oil with a dedicated sales team, driving revenue and bringing the product to market. Through key partnerships, Notis is working with some of the world’s leading researchers on continuous innovations of CBD-related medical products to help patients around the world.

So far, investors are liking the name Notis Global and the new symbol. There is renewed interest in the sector and that will help Notis Global. Investors need to keep in mind that the company filed a Schedule 14A on March 2 about a board meeting on April 15. The primary goal of this meeting is to approve another authorized share increase. This time NGBL is proposing an increase from 400,000,000 to 10,000,000,000 shares. The same filing also said that the company will issue 1.6 billion shares due to note conversion plus shares for warrants. Caution is warranted going forward. We will be updating Insider Financial as soon as we know more. For continuing coverage on NGBL, sign up for our free newsletter today and get our next hot stock pick!Disclosure: We have no position in NGBL and have not been compensated for this article.